Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyHighmark Blueshield Neny drug list Coverage Update…
    Ask Trek AI about this page
    CurrentHighmark Blueshield NenyPolicy N/A

    Free Market Health Drug List

    Customize your policy alerts

    Sign up for all Highmark Blueshield Neny policy alerts

    Know when Highmark Blueshield Neny releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    A combined listing of drugs included in the Free Market Health program, separated by medical benefit (HCPCS/J-codes and Q-codes) and pharmacy benefit (drug names), indicating effective dates; applies to Highmark Blueshield Neny members and providers relying on the payer's drug list.

    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyFree Market Health Drug List
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Last ReviewJan 1, 2026
    Next Review DateN/A
    Key ActionConsult the drug list to determine whether a product is assigned to the medical or pharmacy benefit and note the listed effective date.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2benefit sections (Medical and Pharmacy)

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    40+medical-benefit HCPCS/J/Q codes listed (partial)
    200+pharmacy-benefit drugs listed (partial)
    11/15/2022–06/15/2025effective date range
    PAH/CFindication-specific limits noted

    Covered Drugs by Benefit and Effective Date

    Coverage listing (enumeration only)

    Drugs included in the program by benefit with effective dates; no additional coverage criteria or exclusions are provided in this portion of the document.

    List includes separate sections for Medical Benefit and Pharmacy Benefit drugs, with effective dates shown; no utilization management criteria are specified in this enumeration.

    Medical benefit (examples)

    • Actemra IV (J3262) — Effective Date = 08/01/2021
    • Acthar (J0800) — Effective Date = 04/18/2022
    • Ahzantive (Q5150) — Effective Date = (listed)
    • Aldurazyme (J1931) — Effective Date = (listed)
    • Arcalyst (J2793) — Effective Date = (listed)
    • Avsola (Q5121) — Effective Date = (listed)

    Pharmacy benefit (examples)

    • ABIRATERONE ACETATE — Effective Date = 01/01/2022
    • ABRILADA (CF) — Effective Date = 04/01/2024
    • ACTEMRA (pharmacy entry) — Effective Date = 04/18/2022
    • ADEMPAS — Effective Date = 11/15/2022
    • ADALIMUMAB — Effective Date = 12/01/2023
    • Many additional pharmacy benefit drug names are enumerated in the list with their effective dates (see document).

    Drug list entries

    Drug inclusion on the pharmacy benefit list with stated effective dates; some entries include indication-specific notes.

    Pharmacy benefit drug entries

    • RETEVMO — Effective Date = 12/01/2021
    • REVATIO — Effective Date = 11/15/2022
    • RINVOQ LQ — Effective Date = 01/01/2025
    • SILDENAFIL CITRATE — Effective Date = 11/15/2022

      *PAH Indications Only

    • TIOPRONIN DR — Effective Date = 04/01/2024

    Medical Benefit Codes and Drug Name Lists

    Medical benefit HCPCS/J/Q codes (sample)HCPCS
    J3262Actemra IV
    J0800Acthar
    Q5150Ahzantive
    J1931Aldurazyme
    J2793Arcalyst
    Q5121Avsola
    Drug list (names only)NDC
    List of pharmacy benefit drug names with effective dates (no billing or NDC codes provided in these chunks)

    What Providers Should Know / Do

    Note

    Drug list overview

    The Free Market Health Drug List enumerates all drugs assigned to the program, separated by Medical Benefit (HCPCS/J/Q codes) and Pharmacy Benefit (drug names), and includes the effective date for each listing. Document updated 01/01/2026.

    Prior Authorization

    SILDENAFIL CITRATE — PAH indications only

    SILDENAFIL CITRATE is listed on the Pharmacy Benefit Drug List with an effective date of 11/15/2022 and is limited to pulmonary arterial hypertension (PAH) indications only.

    • Entry: “SILDENAFIL CITRATE *PAH Indications Only, Pharmacy Benefit Drug List .Effective Date = 11/15/2022”
    Prior Authorization

    TOBRAMYCIN SULFATE — CF indications only

    Benefit Section Definitions and Indication Limits

    Benefit section definitions — Medical Benefit Drug List and Pharmacy Benefit Drug List descriptions
    Medical Benefit Drug ListEntries are shown with HCPCS/J-codes or Q-codes and an effective date (examples: J3262 Actemra IV — Effective Date = 08/01/2021; Q5150 Ahzantive — Effective Date = 01/01/2026).
    Pharmacy Benefit Drug ListEntries are shown by drug name and effective date (examples: ABIRATERONE ACETATE — Effective Date = 01/01/2022; ACTEMRA — Effective Date = 04/18/2022).
    PurposeIdentifies which products are assigned to the medical benefit (billed with HCPCS/J/Q codes) versus the pharmacy benefit (filled via pharmacy) for the Free Market Health program.
    Effective dates shownEach listed entry includes an effective date indicating when the product was added to the respective benefit list (document shows multiple dates, e.g. 08/01/2021, 01/01/2022, 01/01/2026).
    PAH-specific limitation — 'PAH Indications Only' annotation
    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyFree Market Health Drug List
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Last ReviewJan 1, 2026
    Next Review DateN/A
    Key ActionConsult the drug list to determine whether a product is assigned to the medical or pharmacy benefit and note the listed effective date.
    SourceLink
    On This Page
    Covered Drugs by Benefit and Effective DateMedical Benefit Codes and Drug Name ListsWhat Providers Should Know / DoBenefit Section Definitions and Indication Limits
    TOBI — Effective Date = 11/15/2022
  1. TOBRAMYCIN SULFATE — Effective Date = 11/15/2022

    *CF Indications Only

  2. TALTZ — Effective Date = 04/18/2022
  3. TIBSOVO — Effective Date = 12/01/2021
  4. VOTRIENT — Effective Date = 01/01/2022
  5. VOSEVI — Effective Date = 04/18/2022
  6. XPOVIO — Effective Date = 12/01/2021
  7. XTANDI — Effective Date = 01/01/2022
  8. Additional pharmacy benefit drug names and effective dates are listed throughout the document (see full list).
  9. TOBRAMYCIN SULFATE is listed on the Pharmacy Benefit Drug List with an effective date of 11/15/2022 and is limited to cystic fibrosis (CF) indications only.

    • Entry: “TOBRAMYCIN SULFATE *CF Indications Only, Pharmacy Benefit Drug List .Effective Date = 11/15/2022”
    Annotation text"*PAH Indications Only" — used to indicate that coverage on the Pharmacy Benefit Drug List applies only for pulmonary arterial hypertension (PAH) indications.
    Example drugSILDENAFIL CITRATE is listed with the annotation '*PAH Indications Only' and an Effective Date = 11/15/2022.
    Scope of limitationThe annotation restricts that drug's inclusion on the pharmacy benefit to PAH-specific uses as shown on the drug list entry.
    Cystic fibrosis-specific limitation — 'CF Indications Only' annotation
    Annotation text"*CF Indications Only" — used to indicate that coverage on the Pharmacy Benefit Drug List applies only for cystic fibrosis (CF) indications.
    Example drugTOBRAMYCIN SULFATE is listed with the annotation '*CF Indications Only' and an Effective Date = 11/15/2022.
    Related CF entriesAdditional CF-designated products in the pharmacy list include formulations noted with (CF) such as ABRILADA(CF) and ADALIMUMAB-AACF(CF) with their respective effective dates.